Guo Hangyuan, Xu Fukang, Sun Aijing, Liu Longbin, Shi Yafei
Department of Cardiology, Shaoxing People's Hospital, Zhejiang, China.
Coron Artery Dis. 2010 Jan;21(1):39-45. doi: 10.1097/MCA.0b013e328333f53b.
This study aimed to find the effects of heparin on atherosclerosis and the production of matrix metalloproteinase (MMP)-2 in low-density lipoprotein receptor-deficient (LDLr(-/-)) mice.
Sixteen 7-week-old LDLr(-/-) mice were randomized to receive sterile water or heparin. The levels of total cholesterol, high-density lipoprotein cholesterol, triglyceride and homocysteine were measured. Mean lesions area was calculated as the total atherosclerotic lesions area and expressed as a percentage of total luminal surface area. The lesions area was measured blindly by the same person using computer-assisted image analysis. The expression and localization of the MMP-2 was examined by immunohistochemistry.
All mice exhibited atherosclerotic lesions in the aortic sinus and aortic surface. Total cholesterol was decreased, while high-density lipoprotein cholesterol was increased in heparin compared with that in control group (P=0.001 and 0.002). Triglyceride was not significantly different between the two groups (P=0.92). The amount of atherosclerotic lesions in the aortic surface was 40.5% lower in heparin group than that in the control group (P<0.001). The mean area of atherosclerotic lesions in the aortic sinus was also less in the heparin group than that in the control group. Coincidently, the expression of MMP-2 in the atherosclerotic lesions in the heparin group was 49.3% lower than that in the control group (P<0.001).
Heparin can inhibit the production of MMP-2 in the atherosclerotic lesions and improve the atherosclerotic lesions in LDLr(-/-) mice.
本研究旨在探究肝素对低密度脂蛋白受体缺陷(LDLr(-/-))小鼠动脉粥样硬化及基质金属蛋白酶(MMP)-2产生的影响。
将16只7周龄的LDLr(-/-)小鼠随机分为两组,分别给予无菌水或肝素。检测总胆固醇、高密度脂蛋白胆固醇、甘油三酯和同型半胱氨酸水平。计算平均病变面积,即动脉粥样硬化病变总面积,并表示为总管腔表面积的百分比。由同一人使用计算机辅助图像分析系统对病变面积进行盲法测量。通过免疫组织化学法检测MMP-2的表达及定位。
所有小鼠的主动脉窦和主动脉表面均出现动脉粥样硬化病变。与对照组相比,肝素组总胆固醇降低,高密度脂蛋白胆固醇升高(P = 0.001和0.002)。两组甘油三酯水平无显著差异(P = 0.92)。肝素组主动脉表面动脉粥样硬化病变量比对照组低40.5%(P < 0.001)。肝素组主动脉窦动脉粥样硬化病变的平均面积也小于对照组。同时,肝素组动脉粥样硬化病变中MMP-2的表达比对照组低49.3%(P < 0.001)。
肝素可抑制LDLr(-/-)小鼠动脉粥样硬化病变中MMP-2的产生,并改善动脉粥样硬化病变。